JPH11228529A5 - - Google Patents

Info

Publication number
JPH11228529A5
JPH11228529A5 JP1998162707A JP16270798A JPH11228529A5 JP H11228529 A5 JPH11228529 A5 JP H11228529A5 JP 1998162707 A JP1998162707 A JP 1998162707A JP 16270798 A JP16270798 A JP 16270798A JP H11228529 A5 JPH11228529 A5 JP H11228529A5
Authority
JP
Japan
Prior art keywords
substituted
phenyl
alkyl
unsubstituted
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998162707A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11228529A (ja
JP4177484B2 (ja
Filing date
Publication date
Priority claimed from DE19719585A external-priority patent/DE19719585A1/de
Priority claimed from DE19719428A external-priority patent/DE19719428A1/de
Application filed filed Critical
Publication of JPH11228529A publication Critical patent/JPH11228529A/ja
Publication of JPH11228529A5 publication Critical patent/JPH11228529A5/ja
Application granted granted Critical
Publication of JP4177484B2 publication Critical patent/JP4177484B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP16270798A 1997-05-09 1998-05-08 置換されたジアミノカルボン酸 Expired - Fee Related JP4177484B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19719585A DE19719585A1 (de) 1997-05-09 1997-05-09 Substituierte Diaminocarbonsäuren
DE19719428:1 1997-05-12
DE19719428A DE19719428A1 (de) 1997-05-12 1997-05-12 Substituierte Diaminocarbonsäuren
DE19719585:7 1997-05-12

Publications (3)

Publication Number Publication Date
JPH11228529A JPH11228529A (ja) 1999-08-24
JPH11228529A5 true JPH11228529A5 (https=) 2005-09-29
JP4177484B2 JP4177484B2 (ja) 2008-11-05

Family

ID=26036417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16270798A Expired - Fee Related JP4177484B2 (ja) 1997-05-09 1998-05-08 置換されたジアミノカルボン酸

Country Status (18)

Country Link
US (2) US6159995A (https=)
EP (1) EP0877019B1 (https=)
JP (1) JP4177484B2 (https=)
KR (1) KR19980086893A (https=)
AR (1) AR012675A1 (https=)
AT (1) ATE210639T1 (https=)
AU (1) AU736700B2 (https=)
BR (1) BR9801604A (https=)
CA (1) CA2237052A1 (https=)
CZ (1) CZ143998A3 (https=)
DE (1) DE59802394D1 (https=)
DK (1) DK0877019T3 (https=)
ES (1) ES2165640T3 (https=)
HU (1) HUP9801045A3 (https=)
ID (1) ID20809A (https=)
PL (1) PL326218A1 (https=)
PT (1) PT877019E (https=)
TR (1) TR199800818A2 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
RU2208609C2 (ru) * 1998-02-04 2003-07-20 Новартис Аг Сульфониламинопроизводные, которые ингибируют разлагающие матрикс металлопротеиназы
RU2217418C2 (ru) * 1998-04-03 2003-11-27 Санкио Компани, Лимитед Сульфонамидное производное, лекарственное средство, способы лечения
ATE227295T1 (de) * 1998-07-16 2002-11-15 Aventis Pharma Gmbh Phosphin- und phosphonsäurederivate als arzneimittel
KR20010102486A (ko) * 1999-03-03 2001-11-15 데이비드 엠 모이어 알케닐- 및 알키닐-함유 메탈로프로테아제 저해제
HK1044935A1 (zh) 1999-03-03 2002-11-08 The Procter & Gamble Company 双异取代的金属蛋白酶抑制剂
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
ES2345977T3 (es) * 2001-03-14 2010-10-07 Novartis Ag Derivados de acido acetico azacicloalquil sustituidos para uso como inhibidores de mmp.
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
GB0412553D0 (en) * 2004-06-04 2004-07-07 Univ Aberdeen Therapeutic agents for the treatment of bone conditions
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7388008B2 (en) * 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
ES2539527T3 (es) * 2005-04-27 2015-07-01 Taimed Biologics, Inc. Método para mejorar la farmacocinética de los inhibidores de las proteasas y de los precursores de los inhibidores de las proteasas
CN101405293B (zh) * 2005-11-30 2013-03-13 中裕新药股份有限公司 天冬氨酰基蛋白酶抑制剂基于赖氨酸的前体药物及其制备方法
US8410300B2 (en) * 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
JP2010520875A (ja) 2007-03-09 2010-06-17 レノビス， インコーポレイテッド Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびその使用
GB0705400D0 (en) 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
GB0817207D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd therapeutic apsac compounds and their use
GB0817208D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd Therapeutic apsap compounds and their use
GB201311361D0 (en) 2013-06-26 2013-08-14 Pimco 2664 Ltd Compounds and their therapeutic use
SI3262028T1 (sl) 2014-12-17 2022-02-28 Pimco 2664 Limited N-(4-hidroksi-4-metil-cikloheksil)-4-fenil-benzensulfonamidne in N-(-4hidroksi-4-metil-cikloheksil)-4-(2-piridil)-benzensulfonamidne spojine in njihova terapevtska uporaba
WO2018113785A1 (zh) * 2016-12-22 2018-06-28 广州华睿光电材料有限公司 含呋喃交联基团的聚合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764262B2 (ja) * 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (https=) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
JPH10501806A (ja) * 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
DK0821671T3 (da) * 1995-04-20 2001-04-23 Pfizer Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
KR980009238A (ko) * 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
IL123901A (en) * 1995-11-17 2003-06-24 Warner Lambert Co Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them
EP0915086A4 (en) 1996-05-24 2001-01-17 Ono Pharmaceutical Co PHENYLSULFONAMIDE DERIVATIVES

Similar Documents

Publication Publication Date Title
JPH11228529A5 (https=)
JPH1160551A5 (https=)
CA2457054A1 (en) Activator of peroxisome proliferator-activated receptor .delta.
JPH10316662A5 (https=)
YU47066B (sh) Postupak za dobijanje derivata tiazolidin-2,4-diona
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MXPA03010584A (es) Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas.
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
CO4770965A1 (es) (metilsulfonil)fenil-2(5h)-furanonas como inhibidores de cox-2
EA201070782A1 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата(sip)
JP2010514786A5 (https=)
JP2004525117A5 (https=)
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
HUP0301404A2 (hu) Azetidinszármazékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
ATE478885T1 (de) Pharmazeutische dopamin-glykokonjugat- zusammensetzungen und verfahren zu deren herstellung
RU94034117A (ru) Производные азола, способы их получения и антигрибковое средство
KR890014534A (ko) 혈당 감소제로서 티아졸리딘디온 유도체
JP2006517201A5 (https=)
DE69828516D1 (de) (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren
KR920004340A (ko) 술폰아미드 유도체
MXPA03011032A (es) Activadores de derivados de oxazol/tiazol del receptor hppar-alfa.
KR930700411A (ko) 시클로헥산올 유도체의 질산 에스테르
EA200200041A1 (ru) Новые четвертичные соединения аммония, способ их получения и фармацевтическое применение
KR960704877A (ko) 이미다졸리딘온 유도체, 이의 산부가염 및 노인성 치매 치료제 (Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia)
EA200101050A1 (ru) Замещенные бензолактамные соединения